Ratio Review: Analyzing Terns Pharmaceuticals Inc (TERN)’s Price-to-Cash and Price-to-Free Cash Flow

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

After finishing at $3.68 in the prior trading day, Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $3.79, up 2.99%. In other words, the price has increased by $2.99% from its previous closing price. On the day, 0.67 million shares were traded. TERN stock price reached its highest trading level at $3.8499 during the session, while it also had its lowest trading level at $3.705.

Ratios:

Our goal is to gain a better understanding of TERN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 30.89 and its Current Ratio is at 30.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On October 31, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $82.

On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.Mizuho initiated its Buy rating on June 22, 2023, with a $16 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’25 when Gengos Andrew bought 10,000 shares for $3.73 per share. The transaction valued at 37,350 led to the insider holds 10,000 shares of the business.

Gengos Andrew bought 5,000 shares of TERN for $19,732 on Jun 16 ’25. The Chief Financial Officer now owns 15,000 shares after completing the transaction at $3.95 per share. On Apr 01 ’25, another insider, Kuriakose Emil, who serves as the Chief Medical Officer of the company, sold 952 shares for $2.49 each. As a result, the insider received 2,366 and left with 53,317 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 331010272 and an Enterprise Value of -2018734.

Stock Price History:

The Beta on a monthly basis for TERN is -0.18, which has changed by -0.4317841 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 18.42%, while the 200-Day Moving Average is calculated to be -26.03%.

Shares Statistics:

The stock has traded on average 1.01M shares per day over the past 3-months and 973580 shares per day over the last 10 days, according to various share statistics. A total of 87.30M shares are outstanding, with a floating share count of 66.42M. Insiders hold about 23.95% of the company’s shares, while institutions hold 77.30% stake in the company. Shares short for TERN as of 1748563200 were 5438997 with a Short Ratio of 5.39, compared to 1745971200 on 5415052. Therefore, it implies a Short% of Shares Outstanding of 5438997 and a Short% of Float of 6.23.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.